HomeCERO • OTCMKTS
add
CERo Therapeutics Holdings Inc
Previous close
$0.085
Day range
$0.085 - $0.10
Year range
$0.050 - $205.00
Market cap
1.92M USD
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.36M | -0.90% |
Net income | -4.86M | -14.86% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.79M | -11.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.95M | -42.39% |
Total assets | 3.91M | -39.75% |
Total liabilities | 8.45M | -17.07% |
Total equity | -4.54M | — |
Shares outstanding | 21.10M | — |
Price to book | -0.01 | — |
Return on assets | -240.40% | — |
Return on capital | 593.95% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -4.86M | -14.86% |
Cash from operations | -3.21M | -16.19% |
Cash from investing | 500.00K | — |
Cash from financing | 1.42M | -42.83% |
Net change in cash | -1.28M | -379.95% |
Free cash flow | -740.99K | 50.75% |
About
Founded
2020
Headquarters
Website
Employees
8
